260 results on '"Copolov, David L."'
Search Results
2. Interhemispheric EEG coherence is reduced in auditory cortical regions in schizophrenia patients with auditory hallucinations
3. Endocrine disturbances in affective disorders and schizophrenia : a selected review of the literature
4. Interhemispheric transfer time in patients with auditory hallucinations: An auditory event-related potential study
5. Diagnostic and symptomatological assessment
6. No Correlation between A(–1438)G Polymorphism in 5-HT2A Receptor Gene Promoter and the Density of Frontal Cortical 5-HT2A Receptors in Schizophrenia
7. Aspects of the measurement, physiology and pathophysiology of immunoreactive beta-endorphin
8. A New Phenomenological Survey of Auditory Hallucinations: Evidence for Subtypes and Implications for Theory and Practice
9. Olfactory sensitivity through the course of psychosis: Relationships to olfactory identification, symptomatology and the schizophrenia odour
10. The management of negative symptoms
11. Effects of N-acetyl cysteine on cognitive function in bipolar disorder
12. Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder
13. Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice
14. Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial
15. Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice
16. Discontinuing Antipsychotic Therapy: A Practical Guide
17. Correlates of the Affective Impact of Auditory Hallucinations in Psychotic Disorders
18. Impairment of Olfactory Identification Ability in Individuals at Ultra-High Risk for Psychosis Who Later Develop Schizophrenia
19. Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann's Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug Treatment
20. Stability of Olfactory Identification Deficits in Neuroleptic-Naive Patients With First-Episode Psychosis
21. Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study
22. Central Auditory Processing in Patients With Auditory Hallucinations
23. Changes in Serotonin2A and GABAA Receptors in Schizophrenia: Studies on the Human Dorsolateral Prefrontal Cortex
24. Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric study
25. [3H]GBR12935 Binds to Membrane from the Human Platelet
26. Psychoses: a primary care perspective
27. Discontinuing antipsychotic therapy
28. Extended treatment with typical and atypical antipsychotic drugs Differential effects on the densities of dopamine D 2-like and GABA A receptors in rat striatum
29. Royal Park Multidiagnostic Instrument for Psychosis: Part I. Rationale and Review
30. Royal Park Multidiagnostic Instrument for Psychosis: Part II. Development, Reliability, and Validity
31. Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation
32. Beyond the evidence: Is there a place for antidepressant combinations in the pharmacotherapy of depression?
33. Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant
34. Clozapine treatment in Australia: a review of haematological monitoring
35. Enkephalins and Endorphins: Clinical, Pharmacological and Therapeutic Implications
36. N-acetylcysteine for major depressive episodes in bipolar disorder
37. N-acetylcysteine for major depressive episodes in bipolar disorder
38. N-acetilcisteína para o tratamento de episódios de depressão maior no transtorno bipolar
39. Secondary hallucinations
40. A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania
41. A New Phenomenological Survey of Auditory Hallucinations: Evidence for Subtypes and Implications for Theory and Practice
42. N-acetylcysteine for major depressive episodes in bipolar disorder
43. N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder
44. Qualitative Methods in Early-Phase Drug Trials
45. Schizophrenia today
46. Evaluation of Treatment in 35 Cases of Bipolar Suicide
47. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility
48. N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial
49. Factors Associated With Compliance and Resistance to Command Hallucinations
50. Differential Role of Serotonergic Projections Arising from the Dorsal and Median Raphe Nuclei in Locomotor Hyperactivity and Prepulse Inhibition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.